PEGASPARGASE

PEGASPARGASE was reported 12377 times

PEGASPARGASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTITHROMBIN III 13 0.8125
1 HUMAN BOCAVIRUS INFECTION 132 0.6984
2 LYMPHOID TISSUE HYPOPLASIA 78 0.5098
3 THYMUS HYPOPLASIA 84 0.4828
4 PERINEAL NECROSIS 19 0.4634
5 CYSTITIS BACTERIAL 106 0.3136
6 HYPOFIBRINOGENAEMIA 303 0.3054
7 NOROVIRUS TEST POSITIVE 99 0.3046
8 ENZYME ACTIVITY DECREASED 6 0.2727
9 MYCOBACTERIUM CHELONAE INFECTION 180 0.2436
10 ANTITHROMBIN III DECREASED 63 0.2308
11 ANTITHROMBIN III DEFICIENCY 18 0.2022
12 ABSCESS BACTERIAL 73 0.2011
13 SECONDARY IMMUNODEFICIENCY 235 0.1934
14 ACRAL LENTIGINOUS MELANOMA 8 0.1905
15 FIBRINOUS BRONCHITIS 14 0.1842
16 FEBRILE BONE MARROW APLASIA 684 0.1608
17 MULTIPLE LENTIGINES SYNDROME 6 0.1579
18 LEWIS-SUMNER SYNDROME 8 0.1509
19 CORONA VIRUS INFECTION 64 0.1488
20 PERIORBITAL INFECTION 11 0.1358
21 BACILLUS TEST POSITIVE 13 0.1313
22 PSEUDOMONAL SEPSIS 220 0.1255
23 ANORECTAL CELLULITIS 7 0.1148
24 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 17 0.0960
25 PERINEAL INFECTION 19 0.0960
26 BACILLUS BACTERAEMIA 10 0.0917
27 PARAINFLUENZAE VIRUS INFECTION 139 0.0913
28 STOMATOCOCCAL INFECTION 11 0.0887
29 OVERGROWTH FUNGAL 9 0.0874
30 ENTEROBACTER INFECTION 143 0.0850
31 DISSEMINATED ASPERGILLOSIS 40 0.0847
32 DISSEMINATED TRICHOSPORONOSIS 6 0.0833
33 BLOOD FIBRINOGEN DECREASED 93 0.0814
34 BACTEROIDES TEST POSITIVE 5 0.0758
35 HUMAN HERPESVIRUS 6 INFECTION 143 0.0756
36 SUPERIOR SAGITTAL SINUS THROMBOSIS 58 0.0726
37 GALLBLADDER OEDEMA 21 0.0717
38 HYPERTRIGLYCERIDAEMIA 419 0.0715
39 RENAL REPLACEMENT THERAPY 9 0.0703
40 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
41 ENCEPHALITIS FUNGAL 6 0.0667
42 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
43 ABSCESS FUNGAL 11 0.0629
44 ESCHERICHIA PYELONEPHRITIS 16 0.0618
45 PYOMYOSITIS 18 0.0608
46 JAUNDICE HEPATOCELLULAR 6 0.0606
47 PARAINFLUENZA VIRUS INFECTION 6 0.0583
48 CONGENITAL APLASIA 18 0.0579
49 ENTEROVIRUS TEST POSITIVE 10 0.0575
50 VIRAEMIA 79 0.0570
51 ENTEROCOCCUS TEST POSITIVE 35 0.0540
52 PSEUDOHYPONATRAEMIA 7 0.0511
53 HUMAN METAPNEUMOVIRUS TEST POSITIVE 6 0.0508
54 PNEUMATOSIS INTESTINALIS 142 0.0497
55 CRYPTOCOCCAL FUNGAEMIA 7 0.0490
56 LENTIGO 24 0.0484
57 RHINOVIRUS INFECTION 186 0.0477
58 CYTOMEGALOVIRUS CHORIORETINITIS 92 0.0471
59 MUCOSAL INFECTION 11 0.0470
60 HUMAN RHINOVIRUS TEST POSITIVE 17 0.0456
61 PROTHROMBIN LEVEL ABNORMAL 7 0.0455
62 CHOLANGITIS INFECTIVE 12 0.0451
63 MUCOCUTANEOUS ULCERATION 10 0.0441
64 PSEUDOMONAS TEST POSITIVE 36 0.0440
65 LEUKAEMIC INFILTRATION 6 0.0429
66 INFECTIVE MYOSITIS 7 0.0419
67 ENCOPRESIS 8 0.0412
68 RHINOCEREBRAL MUCORMYCOSIS 14 0.0403
69 ECTHYMA 16 0.0399
70 GASTROENTERITIS NOROVIRUS 52 0.0391
71 CEREBRAL VENOUS SINUS THROMBOSIS 33 0.0391
72 CANDIDA TEST POSITIVE 16 0.0383
73 CAECITIS 17 0.0378
74 BLOOD CULTURE POSITIVE 111 0.0370
75 HYPERBILIRUBINAEMIA 380 0.0366
76 ENTEROBACTER TEST POSITIVE 9 0.0366
77 FUSARIUM INFECTION 25 0.0357
78 CEREBRAL VENOUS THROMBOSIS 64 0.0352
79 PSEUDOMONAL BACTERAEMIA 30 0.0351
80 ESCHERICHIA TEST POSITIVE 42 0.0351
81 BLOOD LACTIC ACID DECREASED 6 0.0349
82 TRICHOSPORON INFECTION 14 0.0346
83 ZYGOMYCOSIS 16 0.0342
84 CYTOMEGALOVIRUS HEPATITIS 12 0.0339
85 ENTEROBACTER BACTERAEMIA 10 0.0330
86 PANCREATITIS NECROTISING 69 0.0300
87 GRAM STAIN POSITIVE 6 0.0291
88 BRONCHOPULMONARY ASPERGILLOSIS 217 0.0280
89 ANORECTAL INFECTION 7 0.0278
90 MUCORMYCOSIS 71 0.0273
91 ESCHERICHIA SEPSIS 79 0.0272
92 ESCHERICHIA BACTERAEMIA 64 0.0272
93 BACILLUS INFECTION 17 0.0269
94 TRANSVERSE SINUS THROMBOSIS 14 0.0266
95 PULMONARY MUCORMYCOSIS 14 0.0265
96 VENOOCCLUSIVE LIVER DISEASE 131 0.0265
97 ASPERGILLUS INFECTION 174 0.0265
98 CLOSTRIDIUM DIFFICILE COLITIS 275 0.0259
99 OESOPHAGEAL CANDIDIASIS 103 0.0258
100 INTRACARDIAC THROMBUS 79 0.0257
101 SCEDOSPORIUM INFECTION 18 0.0255
102 VENOUS THROMBOSIS 100 0.0255
103 HERPES SIMPLEX TEST POSITIVE 5 0.0251
104 CYTOMEGALOVIRUS VIRAEMIA 109 0.0245
105 FEBRILE NEUTROPENIA 1611 0.0243
106 CAVERNOUS SINUS THROMBOSIS 6 0.0236
107 DEVICE RELATED THROMBOSIS 23 0.0233
108 INTRACRANIAL VENOUS SINUS THROMBOSIS 25 0.0233
109 CARDIAC VENTRICULAR THROMBOSIS 30 0.0232
110 PANCREATIC PSEUDOCYST 18 0.0232
111 ENTEROVIRUS INFECTION 20 0.0231
112 LOWER RESPIRATORY TRACT INFECTION FUNGAL 9 0.0231
113 POTENTIATING DRUG INTERACTION 77 0.0229
114 ENTEROCOLITIS INFECTIOUS 21 0.0228
115 VENOOCCLUSIVE DISEASE 57 0.0227
116 NEUTROPENIC COLITIS 47 0.0227
117 STEROID DIABETES 34 0.0227
118 ENTERITIS 143 0.0223
119 HERPES ZOSTER MENINGOENCEPHALITIS 8 0.0222
120 APLASIA 43 0.0219
121 MIXED ANXIETY AND DEPRESSIVE DISORDER 8 0.0216
122 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
123 LIVER TENDERNESS 6 0.0214
124 CLOSTRIDIUM TEST POSITIVE 46 0.0208
125 STEATOHEPATITIS 11 0.0205
126 KLEBSIELLA TEST POSITIVE 13 0.0200
127 SINUSITIS FUNGAL 16 0.0200
128 INTUSSUSCEPTION 19 0.0199
129 VASCULAR ACCESS COMPLICATION 16 0.0198
130 TRACHEITIS 15 0.0197
131 STAPHYLOCOCCUS TEST POSITIVE 41 0.0194
132 STAPHYLOCOCCAL SEPSIS 95 0.0192
133 FUNGAEMIA 30 0.0190
134 OTITIS MEDIA ACUTE 14 0.0190
135 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 49 0.0190
136 CANDIDA SEPSIS 17 0.0190
137 RESPIRATORY TRACT INFECTION FUNGAL 10 0.0189
138 BRAIN MIDLINE SHIFT 10 0.0189
139 AXILLARY VEIN THROMBOSIS 7 0.0189
140 BACTERIAL INFECTION 351 0.0188
141 ANAL INFLAMMATION 12 0.0188
142 PNEUMONIA NECROTISING 12 0.0185
143 JUGULAR VEIN THROMBOSIS 33 0.0185
144 VULVITIS 6 0.0183
145 BONE MARROW INFILTRATION 7 0.0181
146 METASTASES TO PANCREAS 8 0.0181
147 PERIRECTAL ABSCESS 20 0.0180
148 CEREBRAL THROMBOSIS 50 0.0176
149 PANCREATIC NECROSIS 6 0.0173
150 PANCREATITIS HAEMORRHAGIC 8 0.0172
151 UREAPLASMA INFECTION 7 0.0172
152 STENOTROPHOMONAS INFECTION 23 0.0169
153 DRUG CLEARANCE DECREASED 22 0.0168
154 GASTROINTESTINAL WALL THICKENING 25 0.0167
155 LEUKOENCEPHALOPATHY 62 0.0166
156 GASTROENTERITIS ROTAVIRUS 5 0.0162
157 HYPOALBUMINAEMIA 125 0.0161
158 OEDEMATOUS PANCREATITIS 9 0.0160
159 ANAL ULCER 13 0.0159
160 BACTERIAL TRANSLOCATION 5 0.0158
161 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 150 0.0157
162 SYSTEMIC MYCOSIS 18 0.0154
163 CENTRAL NERVOUS SYSTEM LEUKAEMIA 6 0.0153
164 PNEUMONIA FUNGAL 59 0.0149
165 HEPATOBILIARY DISEASE 9 0.0144
166 FUNGAL TEST POSITIVE 5 0.0142
167 SYSTEMIC CANDIDA 35 0.0139
168 SPLENIC VEIN THROMBOSIS 7 0.0138
169 STREPTOCOCCAL BACTERAEMIA 15 0.0138
170 LIPASE INCREASED 105 0.0137
171 CHRONIC HEPATITIS 11 0.0136
172 STAPHYLOCOCCAL BACTERAEMIA 59 0.0136
173 PERIPHERAL MOTOR NEUROPATHY 19 0.0136
174 ENTEROBACTER SEPSIS 5 0.0135
175 PNEUMATOSIS 6 0.0135
176 MUCOSAL INFLAMMATION 351 0.0134
177 ANISOCORIA 5 0.0132
178 CEREBRAL ASPERGILLOSIS 8 0.0130
179 B PRECURSOR TYPE ACUTE LEUKAEMIA 5 0.0129
180 HAEMORRHAGIC INFARCTION 7 0.0128
181 MINIMAL RESIDUAL DISEASE 6 0.0124
182 HEPATOCELLULAR INJURY 173 0.0122
183 CELLULITIS ORBITAL 7 0.0120
184 HYPOGONADISM 12 0.0119
185 HISTIOCYTOSIS HAEMATOPHAGIC 35 0.0118
186 CITROBACTER INFECTION 5 0.0117
187 CORONAVIRUS TEST POSITIVE 12 0.0117
188 PLATELET TRANSFUSION 15 0.0116
189 SOFT TISSUE NECROSIS 8 0.0116
190 KLEBSIELLA BACTERAEMIA 11 0.0116
191 POST LUMBAR PUNCTURE SYNDROME 12 0.0115
192 POSTURING 6 0.0115
193 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 8 0.0114
194 CENTRAL NERVOUS SYSTEM INFECTION 13 0.0113
195 BLOOD LACTIC ACID INCREASED 59 0.0112
196 PERIORBITAL CELLULITIS 6 0.0112
197 GALLBLADDER ENLARGEMENT 12 0.0111
198 FEEDING INTOLERANCE 5 0.0111
199 COAGULOPATHY 184 0.0110
200 SEPTIC EMBOLUS 9 0.0108
201 INTRACRANIAL HYPOTENSION 7 0.0107
202 KLEBSIELLA SEPSIS 12 0.0106
203 LEUKAEMIA RECURRENT 18 0.0106
204 SUBCLAVIAN VEIN THROMBOSIS 12 0.0105
205 BACTERAEMIA 125 0.0105
206 HERPES SIMPLEX 67 0.0103
207 GASTROINTESTINAL NECROSIS 30 0.0103
208 HYPERAMMONAEMIA 51 0.0102
209 ANGIOCENTRIC LYMPHOMA 5 0.0102
210 PANCREATITIS ACUTE 227 0.0101
211 RESPIRATORY TRACT HAEMORRHAGE 6 0.0101
212 SCROTAL OEDEMA 7 0.0098
213 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 8 0.0098
214 GASTROINTESTINAL ULCER HAEMORRHAGE 11 0.0098
215 FUNGAL SEPSIS 8 0.0096
216 PULMONARY HAEMORRHAGE 75 0.0096
217 HYPERLIPASAEMIA 5 0.0095
218 B-CELL TYPE ACUTE LEUKAEMIA 7 0.0095
219 RECTAL FISSURE 6 0.0095
220 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
221 PULSE ABSENT 44 0.0092
222 BLOOD IMMUNOGLOBULIN A DECREASED 6 0.0092
223 BACTERIAL SEPSIS 30 0.0092
224 GASTROENTERITIS ESCHERICHIA COLI 5 0.0091
225 COAGULATION TEST ABNORMAL 7 0.0091
226 PACKED RED BLOOD CELL TRANSFUSION 12 0.0091
227 CHOLESTASIS 173 0.0090
228 HEPATOMEGALY 88 0.0089
229 OESOPHAGITIS ULCERATIVE 6 0.0088
230 ESCHERICHIA INFECTION 72 0.0087
231 SOFT TISSUE INFECTION 16 0.0087
232 ENTEROCOCCAL SEPSIS 7 0.0086
233 HEPATIC STEATOSIS 160 0.0086
234 BILIRUBIN CONJUGATED INCREASED 20 0.0086
235 STREPTOCOCCAL SEPSIS 10 0.0084
236 CAMPYLOBACTER INFECTION 7 0.0084
237 DERMO-HYPODERMITIS 5 0.0084
238 HYPERPHOSPHATAEMIA 18 0.0084
239 PNEUMONIA VIRAL 26 0.0081
240 VIRAL INFECTION 271 0.0081
241 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41 0.0081
242 HEPATOTOXICITY 180 0.0081
243 PUPIL FIXED 14 0.0081
244 HEART SOUNDS ABNORMAL 6 0.0080
245 PANCREATITIS 418 0.0079
246 AMYLASE INCREASED 29 0.0079
247 QUADRIPARESIS 13 0.0078
248 PSEUDOMONAS INFECTION 67 0.0078
249 VOCAL CORD PARALYSIS 14 0.0078
250 ENTEROCOLITIS 45 0.0078
251 SEPTIC SHOCK 338 0.0078
252 BLOOD BILIRUBIN INCREASED 209 0.0077
253 OESOPHAGEAL STENOSIS 22 0.0077
254 KLEBSIELLA INFECTION 39 0.0077
255 CYTOGENETIC ANALYSIS ABNORMAL 8 0.0076
256 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
257 HYPERLIPIDAEMIA 89 0.0074
258 INTERVERTEBRAL DISCITIS 14 0.0074
259 BONE MARROW FAILURE 146 0.0072
260 CONTINUOUS HAEMODIAFILTRATION 7 0.0072
261 HAEMORRHAGIC CEREBRAL INFARCTION 5 0.0071
262 HEPATITIS CHOLESTATIC 42 0.0070
263 INFECTION IN AN IMMUNOCOMPROMISED HOST 5 0.0070
264 TONIC CLONIC MOVEMENTS 9 0.0069
265 ISCHAEMIC CEREBRAL INFARCTION 8 0.0069
266 OPTIC NERVE DISORDER 11 0.0069
267 ENTEROCOCCAL INFECTION 33 0.0068
268 PROCALCITONIN INCREASED 8 0.0068
269 MYELOSUPPRESSION 245 0.0068
270 ATRIAL THROMBOSIS 14 0.0068
271 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0067
272 VARICELLA 16 0.0067
273 BRAIN HERNIATION 20 0.0067
274 GLYCOSURIA 9 0.0067
275 ORAL HERPES 130 0.0067
276 CATARRH 6 0.0066
277 URETERIC OBSTRUCTION 9 0.0066
278 GAMMA-GLUTAMYLTRANSFERASE INCREASED 146 0.0066
279 IRON OVERLOAD 7 0.0065
280 NEUROLOGICAL DECOMPENSATION 15 0.0065
281 KIDNEY ENLARGEMENT 7 0.0064
282 BLOOD FIBRINOGEN INCREASED 5 0.0063
283 MENINGITIS BACTERIAL 9 0.0063
284 MULTIPLE ORGAN DYSFUNCTION SYNDROME 178 0.0063
285 TUMOUR LYSIS SYNDROME 55 0.0062
286 TACHYPNOEA 84 0.0062
287 HYPOCOAGULABLE STATE 6 0.0062
288 NEUROTOXICITY 108 0.0062
289 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 46 0.0061
290 DISSEMINATED INTRAVASCULAR COAGULATION 86 0.0061
291 HYPERAEMIA 12 0.0061
292 HYPERTRANSAMINASAEMIA 42 0.0060
293 CEREBRAL ISCHAEMIA 31 0.0060
294 DEVICE RELATED INFECTION 92 0.0060
295 HEPATIC CYTOLYSIS 75 0.0059
296 BACTERIAL TEST POSITIVE 13 0.0058
297 BRAIN DEATH 18 0.0058
298 HYPERGLYCAEMIA 211 0.0058
299 PHARYNGEAL INFLAMMATION 7 0.0058
300 FUNGAL INFECTION 188 0.0056
301 BREAKTHROUGH PAIN 13 0.0056
302 CATHETER SITE HAEMORRHAGE 14 0.0056
303 ADENOVIRUS INFECTION 16 0.0055
304 AMMONIA INCREASED 28 0.0055
305 RESPIRATORY DISTRESS 151 0.0055
306 PNEUMONIA KLEBSIELLA 10 0.0054
307 CEREBROSPINAL FLUID LEAKAGE 10 0.0054
308 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
309 HEPATORENAL SYNDROME 9 0.0053
310 PULSELESS ELECTRICAL ACTIVITY 22 0.0053
311 COLITIS 199 0.0052
312 CANDIDA INFECTION 88 0.0052
313 PANCYTOPENIA 291 0.0052
314 ASCITES 152 0.0052
315 PERIPHERAL SENSORY NEUROPATHY 30 0.0051
316 SEPSIS 572 0.0051
317 ACIDOSIS 39 0.0051
318 FEBRILE INFECTION 6 0.0051
319 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9 0.0051
320 RESPIRATORY SYNCYTIAL VIRUS INFECTION 44 0.0050
321 LUNG CONSOLIDATION 14 0.0050
322 PNEUMONIA LEGIONELLA 8 0.0050
323 CORONAVIRUS INFECTION 33 0.0050
324 PNEUMOMEDIASTINUM 9 0.0050
325 HEPATIC FIBROSIS 17 0.0049
326 EMBOLISM VENOUS 15 0.0049
327 ILEUS PARALYTIC 22 0.0049
328 MALNUTRITION 55 0.0049
329 ANGIONEUROTIC OEDEMA 13 0.0049
330 CAPILLARY LEAK SYNDROME 10 0.0048
331 SUBILEUS 10 0.0048
332 HYPOPROTEINAEMIA 9 0.0047
333 PANCREATIC CYST 9 0.0047
334 HEPATOSPLENOMEGALY 12 0.0047
335 CEREBRAL ARTERY OCCLUSION 5 0.0047
336 HEPATIC FAILURE 140 0.0046
337 ENCEPHALITIS 32 0.0046
338 ALANINE AMINOTRANSFERASE INCREASED 282 0.0046
339 EMBOLISM 38 0.0046
340 BLOOD PRESSURE IMMEASURABLE 7 0.0046
341 LYMPHOPENIA 64 0.0045
342 MENINGITIS 30 0.0045
343 CYTOPENIA 55 0.0045
344 DEVICE RELATED SEPSIS 9 0.0045
345 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
346 ATELECTASIS 43 0.0044
347 CHOLECYSTITIS 53 0.0044
348 HYPOGAMMAGLOBULINAEMIA 29 0.0044
349 NEUTROPENIA 597 0.0044
350 QUADRIPLEGIA 9 0.0044
351 PROTHROMBIN TIME PROLONGED 26 0.0043
352 VARICELLA ZOSTER VIRUS INFECTION 9 0.0043
353 PNEUMOPERITONEUM 8 0.0043
354 ANAPHYLACTIC REACTION 237 0.0043
355 BRONCHIAL OBSTRUCTION 6 0.0043
356 H1N1 INFLUENZA 6 0.0043
357 LIP OEDEMA 18 0.0042
358 ESCHERICHIA URINARY TRACT INFECTION 18 0.0042
359 CYSTITIS HAEMORRHAGIC 17 0.0042
360 APLASTIC ANAEMIA 22 0.0042
361 NECROSIS 23 0.0041
362 GAZE PALSY 7 0.0041
363 NON-CARDIAC CHEST PAIN 13 0.0041
364 CHOLECYSTITIS ACUTE 23 0.0041
365 BRAIN OEDEMA 51 0.0040
366 SKIN STRIAE 6 0.0040
367 ILEUS 50 0.0040
368 SPLENIC INFARCTION 7 0.0040
369 RENAL COLIC 9 0.0040
370 MITRAL VALVE DISEASE 7 0.0040
371 DRUG-INDUCED LIVER INJURY 124 0.0039
372 BRAIN ABSCESS 10 0.0039
373 FIBRIN D DIMER INCREASED 14 0.0039
374 ABDOMINAL INFECTION 10 0.0039
375 CALCULUS URINARY 6 0.0039
376 NEUTROPHIL COUNT DECREASED 159 0.0039
377 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
378 ENCEPHALOPATHY 95 0.0039
379 TACHYCARDIA 340 0.0038
380 HAEMODYNAMIC INSTABILITY 29 0.0038
381 PULMONARY INFARCTION 9 0.0038
382 EXTRADURAL HAEMATOMA 5 0.0038
383 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
384 INTESTINAL DILATATION 5 0.0037
385 HYPOXIA 132 0.0037
386 THROMBOCYTOPENIA 418 0.0037
387 APNOEA 29 0.0037
388 MYELOPATHY 7 0.0037
389 METABOLIC ENCEPHALOPATHY 11 0.0037
390 SINUS TACHYCARDIA 52 0.0037
391 EFFUSION 5 0.0037
392 ISCHAEMIC HEPATITIS 5 0.0036
393 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
394 PARTIAL SEIZURES 19 0.0036
395 PLEURITIC PAIN 10 0.0036
396 VENA CAVA THROMBOSIS 6 0.0036
397 UNRESPONSIVE TO STIMULI 92 0.0036
398 URINARY TRACT INFECTION BACTERIAL 9 0.0036
399 CULTURE URINE POSITIVE 5 0.0036
400 BK VIRUS INFECTION 12 0.0036
401 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
402 EPSTEIN-BARR VIRUS INFECTION 22 0.0035
403 FUNGAL SKIN INFECTION 14 0.0035
404 LUNG OPACITY 9 0.0034
405 GRAFT VERSUS HOST DISEASE 24 0.0033
406 TRANSAMINASES INCREASED 74 0.0033
407 CELLULITIS 167 0.0033
408 POLYDIPSIA 13 0.0033
409 MENTAL STATUS CHANGES 91 0.0033
410 HAEMATOLOGICAL INFECTION 8 0.0033
411 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
412 GRANULOCYTE COUNT DECREASED 6 0.0032
413 SHOCK 74 0.0032
414 URINE OUTPUT DECREASED 28 0.0032
415 SHOCK HAEMORRHAGIC 26 0.0032
416 CHOLESTATIC LIVER INJURY 7 0.0031
417 HYPOVOLAEMIC SHOCK 15 0.0031
418 HEMIPARESIS 53 0.0031
419 STREPTOCOCCAL INFECTION 17 0.0031
420 SERUM FERRITIN INCREASED 16 0.0030
421 CELL DEATH 6 0.0030
422 BLOOD ALBUMIN DECREASED 24 0.0030
423 HYPERNATRAEMIA 15 0.0030
424 HAEMORRHAGE INTRACRANIAL 45 0.0030
425 VENTRICULAR ARRHYTHMIA 11 0.0030
426 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
427 BONE MARROW DISORDER 9 0.0030
428 HYPOPHAGIA 76 0.0030
429 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
430 FACIAL PARALYSIS 25 0.0029
431 BRAIN NATRIURETIC PEPTIDE INCREASED 9 0.0029
432 PORTAL HYPERTENSION 9 0.0029
433 STOMATITIS 176 0.0029
434 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
435 INTRACRANIAL PRESSURE INCREASED 16 0.0029
436 VASCULAR DEVICE INFECTION 13 0.0029
437 ASPARTATE AMINOTRANSFERASE INCREASED 151 0.0028
438 FLUID OVERLOAD 41 0.0028
439 PROCTALGIA 18 0.0028
440 RESPIRATORY FAILURE 204 0.0028
441 HERPES VIRUS INFECTION 16 0.0028
442 PLEURAL EFFUSION 168 0.0028
443 CEREBRAL ATROPHY 11 0.0028
444 HYDROCEPHALUS 15 0.0028
445 THROMBOCYTOSIS 10 0.0027
446 INTESTINAL ISCHAEMIA 15 0.0027
447 PALLOR 74 0.0027
448 STRIDOR 8 0.0027
449 ACUTE HEPATIC FAILURE 37 0.0027
450 HYPERCHOLESTEROLAEMIA 26 0.0027
451 PNEUMOCYSTIS JIROVECII PNEUMONIA 27 0.0027
452 HYPERURICAEMIA 11 0.0027
453 ENDOPHTHALMITIS 16 0.0027
454 HYPERCAPNIA 8 0.0027
455 PROTEIN TOTAL DECREASED 10 0.0027
456 DISTRIBUTIVE SHOCK 6 0.0026
457 BLOOD BICARBONATE DECREASED 5 0.0026
458 PERONEAL NERVE PALSY 15 0.0026
459 LEUKOPENIA 132 0.0026
460 HYPERCOAGULATION 5 0.0026
461 AREFLEXIA 7 0.0026
462 GASTROINTESTINAL INJURY 7 0.0026
463 ORAL DISORDER 19 0.0026
464 PETECHIAE 27 0.0026
465 METABOLIC DISORDER 15 0.0026
466 ELECTROLYTE IMBALANCE 30 0.0026
467 OLIGURIA 16 0.0026
468 TOXIC ENCEPHALOPATHY 13 0.0026
469 ADRENAL INSUFFICIENCY 31 0.0026
470 BLOOD TRIGLYCERIDES INCREASED 45 0.0025
471 CYSTITIS 81 0.0025
472 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
473 CACHEXIA 13 0.0025
474 LUNG INFECTION 39 0.0025
475 POLYNEUROPATHY 30 0.0025
476 ANAL HAEMORRHAGE 7 0.0025
477 PROCTITIS 7 0.0025
478 FOETAL GROWTH RESTRICTION 15 0.0025
479 DIALYSIS 35 0.0025
480 STAPHYLOCOCCAL INFECTION 81 0.0025
481 OSTEONECROSIS 80 0.0024
482 STEM CELL TRANSPLANT 6 0.0024
483 CEREBRAL HAEMATOMA 8 0.0024
484 NEUTROPENIC SEPSIS 17 0.0024
485 WOUND DEHISCENCE 8 0.0024
486 NEOPLASM RECURRENCE 8 0.0024
487 HEPATIC ENCEPHALOPATHY 22 0.0024
488 GENERALISED TONIC-CLONIC SEIZURE 39 0.0024
489 APPENDICITIS 22 0.0024
490 HYPOTENSION 472 0.0024
491 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
492 EYE MOVEMENT DISORDER 16 0.0023
493 TYPE 1 DIABETES MELLITUS 14 0.0023
494 HEPATIC LESION 10 0.0023
495 OCULAR ICTERUS 10 0.0023
496 SUBDURAL HAEMATOMA 33 0.0023
497 HEPATITIS TOXIC 6 0.0023
498 HEMIPLEGIA 19 0.0023
499 PYREXIA 785 0.0023
500 FACIAL PARESIS 8 0.0023
501 HYPOKALAEMIA 104 0.0023
502 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
503 ANAL FISSURE 12 0.0022
504 ABDOMINAL PAIN 516 0.0022
505 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38 0.0022
506 ANURIA 19 0.0022
507 PERICARDIAL EFFUSION 51 0.0022
508 HYPONATRAEMIA 124 0.0022
509 CYTOKINE RELEASE SYNDROME 44 0.0022
510 ODYNOPHAGIA 13 0.0022
511 DYSLIPIDAEMIA 11 0.0022
512 BODY TEMPERATURE INCREASED 44 0.0022
513 LUNG INFILTRATION 19 0.0021
514 HAEMODIALYSIS 18 0.0021
515 CHRONIC SINUSITIS 8 0.0021
516 PLATELET COUNT DECREASED 224 0.0021
517 GENERALISED OEDEMA 26 0.0021
518 CEREBRAL HAEMORRHAGE 75 0.0021
519 PULMONARY MASS 31 0.0021
520 GUILLAIN-BARRE SYNDROME 10 0.0021
521 PARONYCHIA 9 0.0020
522 HYPERVOLAEMIA 10 0.0020
523 LARGE INTESTINE PERFORATION 14 0.0020
524 ABDOMINAL TENDERNESS 10 0.0020
525 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
526 NECROTISING FASCIITIS 7 0.0020
527 CARDIO-RESPIRATORY ARREST 83 0.0020
528 JAUNDICE CHOLESTATIC 7 0.0020
529 CONJUNCTIVAL HYPERAEMIA 7 0.0020
530 CHEST X-RAY ABNORMAL 6 0.0020
531 AGRANULOCYTOSIS 36 0.0019
532 LACTIC ACIDOSIS 62 0.0019
533 ANAPHYLACTIC SHOCK 49 0.0019
534 HYPOPHOSPHATAEMIA 14 0.0019
535 LOW BIRTH WEIGHT BABY 15 0.0019
536 ORTHOPNOEA 6 0.0019
537 CARDIAC DYSFUNCTION 7 0.0019
538 HYPOVOLAEMIA 11 0.0019
539 POOR PERIPHERAL CIRCULATION 8 0.0019
540 LIVER INJURY 46 0.0019
541 CATHETER SITE INFECTION 7 0.0018
542 HEPATITIS ACUTE 12 0.0018
543 GASTRIC PERFORATION 5 0.0018
544 BLOOD PHOSPHORUS INCREASED 5 0.0018
545 SEIZURE 211 0.0018
546 OTITIS MEDIA 6 0.0018
547 ABDOMINAL ABSCESS 8 0.0018
548 BRADYCARDIA 96 0.0018
549 FAECES HARD 7 0.0018
550 CARDIOPULMONARY FAILURE 7 0.0018
551 HYPERSENSITIVITY 332 0.0018
552 RESPIRATORY ACIDOSIS 7 0.0018
553 CLOSTRIDIAL INFECTION 6 0.0018
554 MOUTH HAEMORRHAGE 13 0.0018
555 ACUTE RESPIRATORY FAILURE 34 0.0018
556 OXYGEN SATURATION DECREASED 99 0.0018
557 PHOTOPHOBIA 33 0.0018
558 HYPOCALCAEMIA 33 0.0017
559 HEPATIC FUNCTION ABNORMAL 65 0.0017
560 PERIORBITAL OEDEMA 9 0.0017
561 PYELONEPHRITIS 15 0.0017
562 CAROTID ARTERY STENOSIS 6 0.0017
563 CYANOSIS 27 0.0017
564 HYPOTHERMIA 17 0.0017
565 ANAEMIA 318 0.0017
566 CENTRAL VENOUS CATHETERISATION 5 0.0017
567 DUODENITIS 5 0.0016
568 ACUTE KIDNEY INJURY 248 0.0016
569 NEPHROPATHY TOXIC 18 0.0016
570 BLOOD CREATININE DECREASED 5 0.0016
571 ORAL CANDIDIASIS 21 0.0016
572 POLYURIA 13 0.0016
573 IMMUNOSUPPRESSION 14 0.0016
574 HAEMATEMESIS 40 0.0016
575 SUBARACHNOID HAEMORRHAGE 16 0.0016
576 MOTOR DYSFUNCTION 16 0.0016
577 BRONCHOSPASM 22 0.0015
578 FAILURE TO THRIVE 8 0.0015
579 PNEUMOTHORAX 24 0.0015
580 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
581 METABOLIC ACIDOSIS 48 0.0015
582 HYPOGLYCAEMIA 72 0.0015
583 FACE OEDEMA 25 0.0015
584 EYELID OEDEMA 17 0.0015
585 CARDIAC ARREST 120 0.0015
586 WHITE BLOOD CELL COUNT DECREASED 156 0.0014
587 CEREBRAL INFARCTION 35 0.0014
588 TRANSFUSION 15 0.0014
589 PATHOGEN RESISTANCE 13 0.0014
590 INTESTINAL PERFORATION 16 0.0014
591 NEUROPATHY PERIPHERAL 135 0.0014
592 ACUTE MYELOID LEUKAEMIA 22 0.0014
593 ABSCESS LIMB 6 0.0014
594 INFUSION RELATED REACTION 93 0.0014
595 FLUID INTAKE REDUCED 7 0.0014
596 MYOPATHY 12 0.0014
597 CYTOMEGALOVIRUS INFECTION 23 0.0014
598 DYSARTHRIA 52 0.0014
599 SMALL INTESTINAL OBSTRUCTION 17 0.0014
600 HAEMATOTOXICITY 13 0.0014
601 ENDOCARDITIS 7 0.0014
602 LIP SWELLING 45 0.0013
603 LIVER FUNCTION TEST INCREASED 29 0.0013
604 CARDIOTOXICITY 12 0.0013
605 ISCHAEMIC STROKE 24 0.0013
606 BRONCHIECTASIS 9 0.0013
607 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
608 SECOND PRIMARY MALIGNANCY 11 0.0013
609 NEURALGIA 32 0.0013
610 BLOOD UREA INCREASED 22 0.0013
611 VOMITING 611 0.0013
612 ANAL ABSCESS 7 0.0013
613 LARYNGEAL OEDEMA 8 0.0013
614 BRUXISM 7 0.0013
615 CIRCULATORY COLLAPSE 22 0.0013
616 INFUSION SITE EXTRAVASATION 8 0.0013
617 VENTRICULAR TACHYCARDIA 21 0.0013
618 LEUKAEMIA 12 0.0013
619 JAUNDICE 34 0.0013
620 METASTASIS 9 0.0013
621 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
622 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
623 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
624 CANDIDIASIS 5 0.0012
625 BLOOD CALCIUM DECREASED 14 0.0012
626 THROMBOTIC MICROANGIOPATHY 12 0.0012
627 MYOSITIS 11 0.0012
628 NEUROLOGICAL SYMPTOM 7 0.0012
629 BLOOD SODIUM DECREASED 23 0.0012
630 HAEMOGLOBIN DECREASED 125 0.0012
631 ANAPHYLACTOID REACTION 5 0.0012
632 MUCOUS STOOLS 6 0.0012
633 DIABETIC KETOACIDOSIS 29 0.0012
634 RALES 7 0.0012
635 HYPOTONIA 12 0.0012
636 PNEUMONIA BACTERIAL 11 0.0012
637 BRAIN INJURY 12 0.0012
638 HYPERPYREXIA 5 0.0012
639 HYPERTHERMIA 9 0.0012
640 DIARRHOEA HAEMORRHAGIC 11 0.0012
641 INFARCTION 8 0.0012
642 INFECTION 169 0.0012
643 ECCHYMOSIS 8 0.0012
644 GANGRENE 7 0.0012
645 APHASIA 35 0.0012
646 MULTI-ORGAN FAILURE 20 0.0012
647 SKIN NECROSIS 6 0.0012
648 THERAPY PARTIAL RESPONDER 18 0.0012
649 TONSILLITIS 6 0.0011
650 PNEUMONIA 369 0.0011
651 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
652 ORAL PAIN 25 0.0011
653 RHINITIS 9 0.0011
654 ANGIOEDEMA 49 0.0011
655 SCREAMING 7 0.0011
656 BLOOD PRESSURE DECREASED 73 0.0011
657 GASTROENTERITIS 16 0.0011
658 HEPATITIS 28 0.0011
659 ISCHAEMIA 5 0.0011
660 DEEP VEIN THROMBOSIS 70 0.0011
661 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
662 FLANK PAIN 10 0.0011
663 PULMONARY EMBOLISM 101 0.0011
664 HYPERKALAEMIA 37 0.0011
665 GRANULOCYTOPENIA 6 0.0011
666 MYOCARDITIS 12 0.0010
667 GASTROINTESTINAL TOXICITY 5 0.0010
668 HAEMOLYSIS 8 0.0010
669 GASTROINTESTINAL INFLAMMATION 8 0.0010
670 SKIN LESION 28 0.0010
671 TORSADE DE POINTES 8 0.0010
672 DEHYDRATION 136 0.0010
673 CHILLS 119 0.0010
674 CARDIOMYOPATHY 15 0.0010
675 BREATH SOUNDS ABNORMAL 5 0.0010
676 HEPATIC CIRRHOSIS 19 0.0010
677 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
678 LETHARGY 58 0.0010
679 PULMONARY OEDEMA 45 0.0010
680 SKIN INFECTION 11 0.0010
681 GRAND MAL CONVULSION 9 0.0010
682 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
683 CHOLANGITIS 6 0.0010
684 ACUTE CORONARY SYNDROME 8 0.0010
685 LYMPHOCYTE COUNT DECREASED 17 0.0010
686 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
687 BLINDNESS TRANSIENT 7 0.0009
688 CHOLELITHIASIS 31 0.0009
689 COVID-19 PNEUMONIA 11 0.0009
690 RENAL FAILURE 121 0.0009
691 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
692 SWELLING FACE 59 0.0009
693 VENTRICULAR FIBRILLATION 10 0.0009
694 HAEMORRHAGIC STROKE 7 0.0009
695 THERAPY NON-RESPONDER 40 0.0009
696 EYELID PTOSIS 9 0.0009
697 STATUS EPILEPTICUS 10 0.0009
698 LIVER DISORDER 39 0.0009
699 DROOLING 6 0.0009
700 HAEMOPTYSIS 24 0.0009
701 URTICARIA 144 0.0009
702 PRODUCT USE IN UNAPPROVED INDICATION 211 0.0009
703 EJECTION FRACTION DECREASED 13 0.0008
704 RESPIRATORY DISORDER 25 0.0008
705 OEDEMA 45 0.0008
706 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
707 HAEMATOMA 21 0.0008
708 RESPIRATORY TRACT INFECTION 21 0.0008
709 GASTROINTESTINAL HAEMORRHAGE 67 0.0008
710 GASTRITIS 21 0.0008
711 TOXIC SKIN ERUPTION 8 0.0008
712 EPISTAXIS 59 0.0008
713 RESPIRATORY RATE INCREASED 7 0.0008
714 NEUTROPHIL COUNT INCREASED 8 0.0008
715 ANAL INCONTINENCE 7 0.0008
716 THROAT TIGHTNESS 21 0.0008
717 MUSCULAR WEAKNESS 88 0.0008
718 PERITONITIS 16 0.0008
719 INCOHERENT 5 0.0008
720 VENTRICULAR EXTRASYSTOLES 8 0.0008
721 GENERAL PHYSICAL HEALTH DETERIORATION 89 0.0008
722 MOUTH ULCERATION 16 0.0008
723 THROMBOSIS 61 0.0008
724 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
725 DELIRIUM 26 0.0007
726 SENSORY LOSS 6 0.0007
727 HYPERTENSION 156 0.0007
728 DIABETES MELLITUS 56 0.0007
729 OESOPHAGITIS 8 0.0007
730 HYPERCALCAEMIA 9 0.0007
731 HEART RATE INCREASED 72 0.0007
732 LIVER FUNCTION TEST ABNORMAL 21 0.0007
733 BLOOD CREATININE INCREASED 47 0.0007
734 OROPHARYNGEAL PAIN 66 0.0007
735 COUGH 199 0.0007
736 HAEMATOCRIT DECREASED 14 0.0007
737 TOXICITY TO VARIOUS AGENTS 119 0.0007
738 MYDRIASIS 9 0.0007
739 HAEMATURIA 24 0.0007
740 SALIVARY HYPERSECRETION 7 0.0007
741 SKIN HYPERPIGMENTATION 6 0.0007
742 CARDIOGENIC SHOCK 10 0.0007
743 HERPES ZOSTER 40 0.0007
744 MYELODYSPLASTIC SYNDROME 10 0.0007
745 DRUG LEVEL DECREASED 7 0.0007
746 GASTRIC ULCER 13 0.0007
747 INTERSTITIAL LUNG DISEASE 33 0.0007
748 HEPATIC ENZYME INCREASED 46 0.0007
749 IMMUNODEFICIENCY 10 0.0007
750 AGITATION 49 0.0007
751 PNEUMONITIS 18 0.0007
752 C-REACTIVE PROTEIN INCREASED 24 0.0007
753 RETCHING 14 0.0007
754 PERIPHERAL COLDNESS 9 0.0007
755 ABDOMINAL DISTENSION 68 0.0007
756 DECREASED APPETITE 151 0.0006
757 PHARYNGEAL OEDEMA 10 0.0006
758 NERVOUS SYSTEM DISORDER 20 0.0006
759 ASPIRATION 7 0.0006
760 NEOPLASM PROGRESSION 22 0.0006
761 PARALYSIS 9 0.0006
762 HYPOTHYROIDISM 20 0.0006
763 CHROMATURIA 14 0.0006
764 EAR PAIN 12 0.0006
765 ASPHYXIA 5 0.0006
766 GASTRIC HAEMORRHAGE 7 0.0006
767 RENAL INJURY 18 0.0006
768 SARS-COV-2 TEST POSITIVE 8 0.0006
769 DRUG LEVEL INCREASED 10 0.0006
770 RHINORRHOEA 39 0.0006
771 VASCULITIS 7 0.0006
772 HEAD INJURY 19 0.0006
773 SINUSITIS 61 0.0006
774 MELAENA 13 0.0006
775 ATAXIA 7 0.0006
776 MYOCLONUS 7 0.0006
777 CARDIAC FAILURE 47 0.0006
778 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
779 LUNG DISORDER 28 0.0006
780 ERYTHEMA 117 0.0006
781 INCONTINENCE 6 0.0006
782 PHARYNGITIS 7 0.0006
783 RECTAL HAEMORRHAGE 24 0.0006
784 OSTEOMYELITIS 10 0.0006
785 HYPOKINESIA 8 0.0006
786 SYNCOPE 55 0.0005
787 SKIN ULCER 14 0.0005
788 DYSKINESIA 22 0.0005
789 DISEASE PROGRESSION 64 0.0005
790 DRUG INTERACTION 85 0.0005
791 HAEMORRHAGE 56 0.0005
792 COVID-19 93 0.0005
793 PAIN IN JAW 15 0.0005
794 NAUSEA 409 0.0005
795 DIZZINESS POSTURAL 5 0.0005
796 CONSTIPATION 112 0.0005
797 THROAT IRRITATION 23 0.0005
798 GALLBLADDER DISORDER 9 0.0005
799 HYPOMAGNESAEMIA 7 0.0005
800 PAIN IN EXTREMITY 147 0.0005
801 CRYING 18 0.0005
802 PRESYNCOPE 12 0.0005
803 OEDEMA PERIPHERAL 60 0.0005
804 EPILEPSY 15 0.0005
805 HAEMATOCHEZIA 27 0.0005
806 URINARY RETENTION 16 0.0005
807 DERMATITIS ALLERGIC 6 0.0005
808 FLUSHING 48 0.0005
809 INCREASED APPETITE 9 0.0005
810 MEDICATION ERROR 26 0.0005
811 FEELING COLD 13 0.0005
812 IRRITABILITY 28 0.0005
813 BLOOD POTASSIUM DECREASED 14 0.0005
814 BLOOD COUNT ABNORMAL 7 0.0005
815 DYSPHAGIA 43 0.0005
816 DYSPNOEA EXERTIONAL 17 0.0005
817 BONE PAIN 26 0.0004
818 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
819 LEUKOCYTOSIS 8 0.0004
820 TOOTHACHE 8 0.0004
821 DISEASE RECURRENCE 21 0.0004
822 ABSCESS 7 0.0004
823 WHEEZING 26 0.0004
824 RESPIRATORY ARREST 12 0.0004
825 ORAL DISCOMFORT 6 0.0004
826 DRUG RESISTANCE 11 0.0004
827 CONFUSIONAL STATE 69 0.0004
828 CONVULSION 24 0.0004
829 GAIT INABILITY 14 0.0004
830 PERICARDITIS 7 0.0004
831 BLOOD PRESSURE FLUCTUATION 10 0.0004
832 POST PROCEDURAL COMPLICATION 8 0.0004
833 ASTHENIA 156 0.0004
834 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
835 HEADACHE 258 0.0004
836 CHEST PAIN 76 0.0004
837 DISORIENTATION 16 0.0004
838 EYE SWELLING 15 0.0004
839 OFF LABEL USE 353 0.0004
840 ORTHOSTATIC HYPOTENSION 7 0.0004
841 BACK PAIN 92 0.0004
842 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
843 DRUG ERUPTION 7 0.0004
844 GASTROINTESTINAL DISORDER 35 0.0004
845 MUSCLE TWITCHING 9 0.0004
846 DIARRHOEA 252 0.0004
847 RENAL DISORDER 18 0.0004
848 DYSPNOEA 218 0.0004
849 CHEST DISCOMFORT 39 0.0004
850 IMMUNE SYSTEM DISORDER 5 0.0004
851 HALLUCINATION, VISUAL 8 0.0004
852 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
853 RASH ERYTHEMATOUS 18 0.0004
854 PSYCHOTIC DISORDER 11 0.0004
855 HEART RATE DECREASED 13 0.0004
856 RENAL IMPAIRMENT 31 0.0004
857 TREMOR 61 0.0004
858 BLOOD CHOLESTEROL INCREASED 17 0.0004
859 CHOKING 7 0.0004
860 RASH 156 0.0004
861 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
862 BLINDNESS UNILATERAL 5 0.0004
863 DYSURIA 13 0.0004
864 RED BLOOD CELL COUNT DECREASED 10 0.0003
865 HYPERHIDROSIS 45 0.0003
866 LOSS OF CONSCIOUSNESS 44 0.0003
867 SOMNOLENCE 69 0.0003
868 UNDERDOSE 25 0.0003
869 DYSSTASIA 10 0.0003
870 URINARY INCONTINENCE 10 0.0003
871 OESOPHAGEAL CARCINOMA 10 0.0003
872 COMA 16 0.0003
873 ABDOMINAL PAIN UPPER 69 0.0003
874 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
875 ABNORMAL BEHAVIOUR 13 0.0003
876 ABDOMINAL PAIN LOWER 8 0.0003
877 MENORRHAGIA 6 0.0003
878 LACRIMATION INCREASED 9 0.0003
879 FULL BLOOD COUNT DECREASED 6 0.0003
880 THERAPEUTIC RESPONSE DECREASED 18 0.0003
881 SWELLING 27 0.0003
882 DERMATITIS 6 0.0003
883 CEREBROVASCULAR ACCIDENT 48 0.0003
884 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
885 GASTROENTERITIS VIRAL 5 0.0003
886 FLUID RETENTION 14 0.0003
887 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
888 LABORATORY TEST ABNORMAL 8 0.0003
889 RASH GENERALISED 7 0.0003
890 CONTUSION 26 0.0003
891 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
892 FLATULENCE 15 0.0003
893 BLOOD URINE PRESENT 5 0.0003
894 NEPHROLITHIASIS 12 0.0003
895 DRUG ADMINISTRATION ERROR 8 0.0003
896 PARAESTHESIA 41 0.0003
897 RASH PRURITIC 14 0.0003
898 WEIGHT DECREASED 72 0.0003
899 DYSTONIA 5 0.0003
900 THERAPY CESSATION 13 0.0003
901 MOVEMENT DISORDER 8 0.0002
902 DEATH 211 0.0002
903 FEELING HOT 15 0.0002
904 SKIN DISCOLOURATION 11 0.0002
905 NASAL CONGESTION 14 0.0002
906 RENAL FAILURE ACUTE 10 0.0002
907 COGNITIVE DISORDER 11 0.0002
908 GAIT DISTURBANCE 45 0.0002
909 NECK PAIN 13 0.0002
910 FAECES DISCOLOURED 5 0.0002
911 PRODUCTIVE COUGH 11 0.0002
912 FALL 76 0.0002
913 LYMPHADENOPATHY 8 0.0002
914 MALAISE 99 0.0002
915 BLOOD GLUCOSE INCREASED 42 0.0002
916 DRUG INTOLERANCE 21 0.0002
917 TREATMENT FAILURE 18 0.0002
918 HYPOAESTHESIA 32 0.0002
919 PRURITUS 82 0.0002
920 SPEECH DISORDER 11 0.0002
921 BLOOD GLUCOSE DECREASED 10 0.0002
922 INFLUENZA 23 0.0002
923 ACUTE MYOCARDIAL INFARCTION 6 0.0002
924 ABASIA 5 0.0002
925 EXTRAPYRAMIDAL DISORDER 5 0.0002
926 URINARY TRACT INFECTION 34 0.0002
927 CONDITION AGGRAVATED 60 0.0002
928 EMOTIONAL DISORDER 6 0.0002
929 DIZZINESS 97 0.0002
930 DIPLOPIA 5 0.0002
931 RHABDOMYOLYSIS 8 0.0002
932 BLOOD PRESSURE INCREASED 29 0.0002
933 PRODUCT USE ISSUE 35 0.0002
934 MENTAL DISORDER 8 0.0002
935 TREATMENT NONCOMPLIANCE 10 0.0002
936 FATIGUE 142 0.0002
937 THERAPY INTERRUPTED 13 0.0002
938 PAIN 110 0.0002
939 EYE PAIN 10 0.0002
940 MYALGIA 30 0.0002
941 TINNITUS 8 0.0002
942 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
943 MUSCULOSKELETAL STIFFNESS 15 0.0002
944 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
945 ARRHYTHMIA 8 0.0002
946 ANXIETY 48 0.0002
947 DISCOMFORT 10 0.0002
948 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
949 WEIGHT INCREASED 36 0.0002
950 INTESTINAL OBSTRUCTION 6 0.0002
951 DRUG INEFFECTIVE 204 0.0002
952 MUSCULOSKELETAL PAIN 8 0.0002
953 ADVERSE EVENT 14 0.0002
954 BRONCHITIS 11 0.0001
955 OCULAR HYPERAEMIA 7 0.0001
956 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
957 VISION BLURRED 20 0.0001
958 PERIPHERAL SWELLING 22 0.0001
959 SUICIDAL IDEATION 13 0.0001
960 MOBILITY DECREASED 10 0.0001
961 VAGINAL HAEMORRHAGE 6 0.0001
962 DRUG EFFECT INCOMPLETE 5 0.0001
963 ARTHRALGIA 55 0.0001
964 EMOTIONAL DISTRESS 16 0.0001
965 BLISTER 7 0.0001
966 DYSPHONIA 7 0.0001
967 ABDOMINAL DISCOMFORT 19 0.0001
968 VISUAL IMPAIRMENT 14 0.0001
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
970 PALPITATIONS 13 0.0001
971 AGGRESSION 5 0.0001
972 DISTURBANCE IN ATTENTION 5 0.0001
973 BALANCE DISORDER 8 0.0001
974 UNEVALUABLE EVENT 7 0.0001
975 DEPRESSION 20 0.0001
976 INSOMNIA 23 0.0001
977 SLEEP DISORDER 6 0.0001
978 ATRIAL FIBRILLATION 8 0.0001
979 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
980 CHRONIC KIDNEY DISEASE 6 0.0001
981 ADVERSE DRUG REACTION 7 0.0001
982 ALOPECIA 15 0.0001
983 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
984 MEMORY IMPAIRMENT 10 0.0001
985 SKIN EXFOLIATION 6 0.0001
986 HALLUCINATION 5 0.0001
987 FEELING ABNORMAL 15 0.0001
988 OVERDOSE 12 0.0001
989 NASOPHARYNGITIS 10 0.0001
990 MUSCLE SPASMS 8 0.0000
991 MYOCARDIAL INFARCTION 7 0.0000
992 HOSPITALISATION 6 0.0000
993 NO ADVERSE EVENT 6 0.0000